GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is classed by the SEC under X-Ray Apparatus & Tubes & Related Irradiation Apparatus (industry code 3844), based in Chicago, IL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $21 billion and a profit of $2.1 billion (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 6.1 out of ten, 8 of 9 metrics filed and 1 estimated: past 7.3 out of ten, present 6.1 out of ten, future 4.9 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.5 out of ten. No warning events in its filings since 2022. 75th percentile among 24 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 8.2 out of ten. +4.1% a year over 5 filed years; profitable in 5 of 5. 82nd percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 5.0 out of ten. Share count grew 0.3% a year. 6% of cash flow returned. Insiders: 0 sales, 8 purchases. 49th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 5.0 out of ten. ROE 20%: 20¢ of profit per shareholder dollar. Leverage 72%: owes 72¢ per asset dollar. 50th percentile among 24 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 6.9 out of ten. top 31% of 23 in its family; net margin 10.1%. 69th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 7.1 out of ten. CrossAssetData estimate 7.1/10, confidence 35 of 100 (one part). 71st percentile among 19 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
- Room to expand (future): 4.2 out of ten. bottom 42% of 23 in its family for room to expand. 42nd percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 6.3 out of ten. top 37% of 23 in its family for growth drivers. 63rd percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 4.0 out of ten. bottom 40% of 22 in its family for expectations against reality. 40th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-04 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-29 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-29 (on EDGAR). Newest filing: Form 8-K, 2026-09-22. Filings on record since 2022. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Product 66%, Service 34%. By geography: All other countries 46%, United States 44%, China 10%. As tagged in its annual report (Form 10-K, filed 2026-02-04).
Who runs it
Arduini, Peter J (President and CEO); O'Neill, Kevin Michael (CEO, PDx); Rackliffe, Philip (CEO, AIS); Bankes, Jeannette (CEO, Patient Care Solutions); Rott, Roland (CEO, Imaging); Grogan, William K (Chief Financial Officer); Saccaro, James (Chief Financial Officer); Estrampes, Catherine (Chief Commer. & Growth Officer); Holton, Adam Y (Chief People Officer); Kass-Hout, Taha (Chief Technology Officer); and 10 more. 20 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.